The evolving role of clinical trials in CLL (chronic lymphocytic leukemia)
Hi,
As many of you know, I am alive today because of my entering two phase I clinical trials, one for PCI-32765 that later became known as ibrutinib and another for a CAR-T drug.
Clinical trials are always great, right?
Well Dr. Furman has a more nuanced answer to that from our interview at ASH 2018. And he is clearly putting the patient first.
Well Dr. Furman has a more nuanced answer to that from our interview at ASH 2018. And he is clearly putting the patient first.
No-one is saying that clinical trials are not the best source of evidence, but what questions are being answered and at what cost to patients need to be carefully considered.
See: https://cllsociety.org/2019/01/ash-2018-dr-furman-on-the-evolving-role-of-clinical-trials-in-cll/ for the interview.
Lots more news on the website. Hard to keep up
And please don’t forget to register our upcoming educational forums in Duarte, Charlotte, Seattle, Portland and Houston in the next 60 days.
We are all in this together.
Brian
Cllsociety.org
posted by Brian Koffman at
11:59 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home